Antiphospholpid Syndrome: Risk Factor for Preeclampsia
Publish place: 7th International Conference on New Findings in Midwifery, Obstetrics, Gynecology and Infertility
Publish Year: 1401
نوع سند: مقاله کنفرانسی
زبان: English
View: 226
This Paper With 10 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
ICMWMI07_050
تاریخ نمایه سازی: 17 مرداد 1401
Abstract:
Antiphospholipid syndrome is the most frequently acquired risk factor for a treatable cause of recurrent abortion, stillbirth, preeclampsia, intrauterine death, premature birth, and fetal growth restriction. The purpose of this study was to review current literature about the antiphospholipid syndrome as a risk factor for preeclampsia. Systematic literature searches using pre-specified terms were performed on PubMed, Ovid EMBASE, Ovid Medline, Cochrane library, Clinicaltrials.gov, and Web of Science from database inception dates to Jun ۲۰۲۲. Antiphospholipid syndrome, in relation to pregnancy, is characterized by the presence of antiphospholipid autoantibodies in association with repeated fetal loss and complications such as preeclampsia retarded fetal growth, or placental insufficiency.
Keywords:
Authors
Mahmood Abedinzade
Associate Professor, Medical Biotechnology Research Center, School of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran
Zahra Bostani Khalesi
Associate Professor, Department of Midwifery, School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran